Yuichi Tominaga

This inventor holds 6 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 3 EPO patents. Top assignees: Daiichi Sankyo Company, Limited, National Cancer Center. Active years: 2012-2020.

USPTO Granted Patents = 6 (Patent Applications = 1)

% Patents Active = 66.7

CIPO Patents = 1

EPO Patents = 3 (Patent Applications = 2)

Average Co-Inventor Count = 6.5

ph-index = 4

Forward Citations = 59(Granted Patents)

Location History:

Tokyo, JP (2012 - 2015)
Shinagawa-ku, JP (2015 - 2020)

Company Filing History:

6 out of 460

Daiichi Sankyo Company, Limited

patents

1 out of 263

National Cancer Center

patents

where one patent can have more than one assignee

Years Active: 2012-2020

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10768179 - Method for predicting responsiveness to cancer treatment using p300-inhibiting compound (2020-09-08),

2. 9751887 - Imidazo[1,2-b]pyridazine derivatives as kinase inhibitors (2017-09-05),

3. 9187489 - Imidazo[1,2-b]pyridazine derivatives as kinase inhibitors (2015-11-17),

4. 8933103 - Pyridone derivatives (2015-01-13),

5. 8309546 - Morpholinopurine derivatives (2012-11-13),

6. 8097622 - Morpholinopurine derivatives (2012-01-17),

I specialize in innovations, inventions, inventors, patent attorneys, assignees, and patents. If you have any questions related to these areas, feel free to ask.

Profile summary based on public USPTO records.